IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 88, Issue 2, Pages 106-112
Publisher
BMJ
Online
2015-09-30
DOI
10.1136/jnnp-2015-311486
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intravenous immunoglobulin products contain specific antibodies to recombinant human tau protein
- (2013) Lynnae M. Smith et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
- (2013) Richard Dodel et al. LANCET NEUROLOGY
- Arterial spin labeled MRI in prodromal Alzheimer's disease: A multi-site study
- (2013) Ze Wang et al. NeuroImage-Clinical
- Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment
- (2012) Liyong Wu et al. PLoS One
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer’s disease pathogenesis
- (2010) Delphine Boche et al. ACTA NEUROPATHOLOGICA
- Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans
- (2010) Paul S. Aisen et al. Alzheimers & Dementia
- Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
- (2010) Geert De Meyer ARCHIVES OF NEUROLOGY
- Intravenous Immunoglobulins as a Treatment for Alzheimerʼs Disease
- (2010) Richard Dodel et al. DRUGS
- Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
- (2010) Johanna Magga et al. Journal of Neuroinflammation
- Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort
- (2010) Shannon L. Risacher et al. NEUROBIOLOGY OF AGING
- Report of the task force on designing clinical trials in early (predementia) AD
- (2010) P. S. Aisen et al. NEUROLOGY
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders
- (2009) H. Fillit et al. NEUROLOGY
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease
- (2008) Norman R. Relkin et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search